310 related articles for article (PubMed ID: 17652140)
1. DNA damage induces alternative lengthening of telomeres (ALT) associated promyelocytic leukemia bodies that preferentially associate with linear telomeric DNA.
Fasching CL; Neumann AA; Muntoni A; Yeager TR; Reddel RR
Cancer Res; 2007 Aug; 67(15):7072-7. PubMed ID: 17652140
[TBL] [Abstract][Full Text] [Related]
2. Alternative lengthening of telomeres in mammalian cells.
Henson JD; Neumann AA; Yeager TR; Reddel RR
Oncogene; 2002 Jan; 21(4):598-610. PubMed ID: 11850785
[TBL] [Abstract][Full Text] [Related]
3. Telomerase-independent telomere length maintenance in the absence of alternative lengthening of telomeres-associated promyelocytic leukemia bodies.
Fasching CL; Bower K; Reddel RR
Cancer Res; 2005 Apr; 65(7):2722-9. PubMed ID: 15805271
[TBL] [Abstract][Full Text] [Related]
4. A novel telomere structure in a human alternative lengthening of telomeres cell line.
Marciniak RA; Cavazos D; Montellano R; Chen Q; Guarente L; Johnson FB
Cancer Res; 2005 Apr; 65(7):2730-7. PubMed ID: 15805272
[TBL] [Abstract][Full Text] [Related]
5. The SMC5/6 complex maintains telomere length in ALT cancer cells through SUMOylation of telomere-binding proteins.
Potts PR; Yu H
Nat Struct Mol Biol; 2007 Jul; 14(7):581-90. PubMed ID: 17589526
[TBL] [Abstract][Full Text] [Related]
6. A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas.
Henson JD; Hannay JA; McCarthy SW; Royds JA; Yeager TR; Robinson RA; Wharton SB; Jellinek DA; Arbuckle SM; Yoo J; Robinson BG; Learoyd DL; Stalley PD; Bonar SF; Yu D; Pollock RE; Reddel RR
Clin Cancer Res; 2005 Jan; 11(1):217-25. PubMed ID: 15671549
[TBL] [Abstract][Full Text] [Related]
7. De novo assembly of a PML nuclear subcompartment occurs through multiple pathways and induces telomere elongation.
Chung I; Leonhardt H; Rippe K
J Cell Sci; 2011 Nov; 124(Pt 21):3603-18. PubMed ID: 22045732
[TBL] [Abstract][Full Text] [Related]
8. PML induces compaction, TRF2 depletion and DNA damage signaling at telomeres and promotes their alternative lengthening.
Osterwald S; Deeg KI; Chung I; Parisotto D; Wörz S; Rohr K; Erfle H; Rippe K
J Cell Sci; 2015 May; 128(10):1887-900. PubMed ID: 25908860
[TBL] [Abstract][Full Text] [Related]
9. Telomerase suppresses formation of ALT-associated single-stranded telomeric C-circles.
Plantinga MJ; Pascarelli KM; Merkel AS; Lazar AJ; von Mehren M; Lev D; Broccoli D
Mol Cancer Res; 2013 Jun; 11(6):557-67. PubMed ID: 23505069
[TBL] [Abstract][Full Text] [Related]
10. Assembly of functional ALT-associated promyelocytic leukemia bodies requires Nijmegen Breakage Syndrome 1.
Wu G; Jiang X; Lee WH; Chen PL
Cancer Res; 2003 May; 63(10):2589-95. PubMed ID: 12750284
[TBL] [Abstract][Full Text] [Related]
11. Alternative lengthening of telomeres is a self-perpetuating process in ALT-associated PML bodies.
Zhang JM; Genois MM; Ouyang J; Lan L; Zou L
Mol Cell; 2021 Mar; 81(5):1027-1042.e4. PubMed ID: 33453166
[TBL] [Abstract][Full Text] [Related]
12. Telomere length maintenance--an ALTernative mechanism.
Royle NJ; Foxon J; Jeyapalan JN; Mendez-Bermudez A; Novo CL; Williams J; Cotton VE
Cytogenet Genome Res; 2008; 122(3-4):281-91. PubMed ID: 19188697
[TBL] [Abstract][Full Text] [Related]
13. Suppression of alternative lengthening of telomeres by Sp100-mediated sequestration of the MRE11/RAD50/NBS1 complex.
Jiang WQ; Zhong ZH; Henson JD; Neumann AA; Chang AC; Reddel RR
Mol Cell Biol; 2005 Apr; 25(7):2708-21. PubMed ID: 15767676
[TBL] [Abstract][Full Text] [Related]
14. Identification of candidate alternative lengthening of telomeres genes by methionine restriction and RNA interference.
Jiang WQ; Zhong ZH; Henson JD; Reddel RR
Oncogene; 2007 Jul; 26(32):4635-47. PubMed ID: 17297460
[TBL] [Abstract][Full Text] [Related]
15. Ku suppresses formation of telomeric circles and alternative telomere lengthening in Arabidopsis.
Zellinger B; Akimcheva S; Puizina J; Schirato M; Riha K
Mol Cell; 2007 Jul; 27(1):163-9. PubMed ID: 17612498
[TBL] [Abstract][Full Text] [Related]
16. A three-dimensional colocalization RNA interference screening platform to elucidate the alternative lengthening of telomeres pathway.
Osterwald S; Wörz S; Reymann J; Sieckmann F; Rohr K; Erfle H; Rippe K
Biotechnol J; 2012 Jan; 7(1):103-16. PubMed ID: 21648092
[TBL] [Abstract][Full Text] [Related]
17. Localization of hRad9, hHus1, hRad1, and hRad17 and caffeine-sensitive DNA replication at the alternative lengthening of telomeres-associated promyelocytic leukemia body.
Nabetani A; Yokoyama O; Ishikawa F
J Biol Chem; 2004 Jun; 279(24):25849-57. PubMed ID: 15075340
[TBL] [Abstract][Full Text] [Related]
18. DNA methyltransferases control telomere length and telomere recombination in mammalian cells.
Gonzalo S; Jaco I; Fraga MF; Chen T; Li E; Esteller M; Blasco MA
Nat Cell Biol; 2006 Apr; 8(4):416-24. PubMed ID: 16565708
[TBL] [Abstract][Full Text] [Related]
19. Cell cycle dependent telomere regulation by telomerase in human bone marrow mesenchymal stem cells.
Zhao YM; Li JY; Lan JP; Lai XY; Luo Y; Sun J; Yu J; Zhu YY; Zeng FF; Zhou Q; Huang H
Biochem Biophys Res Commun; 2008 May; 369(4):1114-9. PubMed ID: 18339310
[TBL] [Abstract][Full Text] [Related]
20. Probing PML body function in ALT cells reveals spatiotemporal requirements for telomere recombination.
Draskovic I; Arnoult N; Steiner V; Bacchetti S; Lomonte P; Londoño-Vallejo A
Proc Natl Acad Sci U S A; 2009 Sep; 106(37):15726-31. PubMed ID: 19717459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
